Skip to main content
Smart Investors Daily
PA

NYSE · PAHC

Phibro Animal Health Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

$34.08

Down-$1.49 (-4.19%)

Updated Nov 20, 2026, 10:55 AM

SID Score

4.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.65B
P/E ratio
24.36
Dividend yield
1.41%
52-week range
$28.25 – $60.08
Volume
101.72K
Avg. volume
292.23K

Price performance · PAHC

PAHC price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

PAHC closed at $34.08 after 21 trading sessions, down 14.39% for the selected period.

Last close
$34.08
Period change
-14.39%
Period low
$32.96
Period high
$39.81
Daily close
View OHLC price history
PAHC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$35.37$35.37$33.91$34.08101.72K
Nov 18, 2026$34.56$35.74$34.50$35.57109.17K
Nov 17, 2026$34.90$35.635$34.26$34.92130.09K
Nov 16, 2026$36.04$36.075$34.835$35.02193.57K
Nov 13, 2026$35.69$36.40$35.15$35.97293.91K
Nov 12, 2026$35.19$35.51$34.79$35.46130.13K
Nov 11, 2026$34.58$35.30$34.28$35.15145.58K
Nov 10, 2026$34.48$35.24$33.98$34.64223.79K
Nov 9, 2026$33.33$35.03$33.07$34.61282.68K
Nov 6, 2026$35.21$35.67$32.91$32.96283.68K
Nov 5, 2026$38.09$39.46$35.00$35.40348.69K
Nov 4, 2026$38.61$39.715$38.315$39.43266.66K
Nov 3, 2026$38.93$39.53$37.35$37.65289.49K
Nov 2, 2026$39.41$40.54$38.05$38.74250.44K
Oct 30, 2026$39.38$39.95$38.49$38.88182.78K
Oct 29, 2026$38.35$39.01$38.275$38.86100.83K
Oct 28, 2026$38.18$38.455$37.60$37.88168.86K
Oct 27, 2026$38.95$39.26$38.30$38.38118.87K
Oct 26, 2026$38.80$39.57$38.70$39.03144.65K
Oct 23, 2026$39.51$39.51$38.62$38.80102.86K
Oct 22, 2026$39.37$40.87$39.28$39.81254.38K

Latest PAHC news

The latest Smart Investors Daily articles mentioning PAHC.

PAHC research

Overview

Company profile and research snapshot.

Company profile

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$34.00
Implied upside
—
Analysts
—
PAHC recent ratings
DateFirmRatingTarget
May 14, 2026CitigroupNeutral—
Apr 15, 2026CitigroupNeutral—
Nov 7, 2025JP MorganOverweight—
Aug 29, 2025B of A SecuritiesUnderperform—
Jul 7, 2025JP MorganOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.